Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- $6.69 million
- Book Value:
- Revenue TTM:
- Operating Margin TTM:
- Gross Profit TTM:
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
Akanda Corp had its IPO on 2022-03-15 under the ticker symbol AKAN.
The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Akanda Corp has a staff strength of 0 employees.
Shares of Akanda Corp opened at $1.06 at the start of the last trading session i.e. 2023-03-25.
The stocks traded within a range of $1.05 - $1.21, and closed at $1.13.
This is a +6.81% increase from the previous day's closing price.
A total volume of 199,100 shares were traded at the close of the day’s session.
In the last one week, shares of Akanda Corp have slipped by -8.13%.
Akanda Corp's Key Ratios
Akanda Corp has a market cap of $6.69 million, indicating a price to book ratio of 13.2236 and a price to sales ratio of 142.1272.
In the last 12-months Akanda Corp’s revenue was $110592 with a gross profit of $-719799 and an EBITDA of $-15662920. The EBITDA ratio measures Akanda Corp's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Akanda Corp’s operating margin was -15694.03% while its return on assets stood at -69.33% with a return of equity of 0%.
In Q4, Akanda Corp’s quarterly earnings growth was a positive 0% while revenue growth was a positive 1758.1%.
Akanda Corp’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at $-0.24 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Akanda Corp’s profitability.
Akanda Corp stock is trading at a EV to sales ratio of 298.5354 and a EV to EBITDA ratio of -1.838. Its price to sales ratio in the trailing 12-months stood at 142.1272.
Akanda Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $43.48 million
- Total Liabilities
- $6.27 million
- Operating Cash Flow
- Capital Expenditure
- Dividend Payout Ratio
Akanda Corp ended 2023 with $43.48 million in total assets and $0 in total liabilities. Its intangible assets were valued at $43.48 million while shareholder equity stood at $34.64 million.
Akanda Corp ended 2023 with $0 in deferred long-term liabilities, $6.27 million in other current liabilities, 47101209.00 in common stock, $-12024032.00 in retained earnings and $0 in goodwill. Its cash balance stood at $3.93 million and cash and short-term investments were $4.27 million. The company’s total short-term debt was $1,262,785 while long-term debt stood at $2.57 million.
Akanda Corp’s total current assets stands at $6.94 million while long-term investments were $0 and short-term investments were $337145.00. Its net receivables were $726865.00 compared to accounts payable of $4.49 million and inventory worth $895774.00.
In 2023, Akanda Corp's operating cash flow was $0 while its capital expenditure stood at $0.
Comparatively, Akanda Corp paid $0 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
Akanda Corp stock is currently trading at $1.13 per share. It touched a 52-week high of $31 and a 52-week low of $31. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $2.01 and 200-day moving average was $4.63 The short ratio stood at 0.11 indicating a short percent outstanding of 0%.
Around 6594.5% of the company’s stock are held by insiders while 156.7% are held by institutions.
Frequently Asked Questions About Akanda Corp
Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)
Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products in the United Kingdom, Lesotho, and internationally. It intends to supply cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.